Correlation Between Bionano Genomics and Straumann Holding

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bionano Genomics and Straumann Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bionano Genomics and Straumann Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bionano Genomics and Straumann Holding AG, you can compare the effects of market volatilities on Bionano Genomics and Straumann Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bionano Genomics with a short position of Straumann Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bionano Genomics and Straumann Holding.

Diversification Opportunities for Bionano Genomics and Straumann Holding

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between Bionano and Straumann is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Bionano Genomics and Straumann Holding AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Straumann Holding and Bionano Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bionano Genomics are associated (or correlated) with Straumann Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Straumann Holding has no effect on the direction of Bionano Genomics i.e., Bionano Genomics and Straumann Holding go up and down completely randomly.

Pair Corralation between Bionano Genomics and Straumann Holding

Given the investment horizon of 90 days Bionano Genomics is expected to under-perform the Straumann Holding. In addition to that, Bionano Genomics is 2.32 times more volatile than Straumann Holding AG. It trades about -0.14 of its total potential returns per unit of risk. Straumann Holding AG is currently generating about 0.02 per unit of volatility. If you would invest  1,207  in Straumann Holding AG on September 3, 2024 and sell it today you would earn a total of  87.00  from holding Straumann Holding AG or generate 7.21% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Bionano Genomics  vs.  Straumann Holding AG

 Performance 
       Timeline  
Bionano Genomics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bionano Genomics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Straumann Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Straumann Holding AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Bionano Genomics and Straumann Holding Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bionano Genomics and Straumann Holding

The main advantage of trading using opposite Bionano Genomics and Straumann Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bionano Genomics position performs unexpectedly, Straumann Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Straumann Holding will offset losses from the drop in Straumann Holding's long position.
The idea behind Bionano Genomics and Straumann Holding AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators